Post-earnings recap
Reported
Thu, Jul 30, 2026
EPS actual
$1.19
EPS est.
$0.85
EPS surprise
+39.34%
1-day move
+3.10%
Merit Medical Systems reported strong earnings per share, significantly exceeding expectations, which contributed to a 3.10% increase in stock price. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may view the EPS beat as a positive sign for the company's profitability.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.19 | $1.02 | +39.34% |
| Revenue | — | $409M | — |
No transcript is on record, and the analysis is based on numerical results only.
Merit Medical Systems, Inc. (MMSI) is a healthcare company that specializes in medical supplies and devices. With a market cap of $5 billion, it plays a crucial role in providing essential products for various medical procedures, which is increasingly important as healthcare demands grow.
Last quarter
In Q1-2026, Merit Medical reported an EPS of $0.94, significantly beating the estimate of $0.73, which led to a 5.15% increase in stock price the following day. The strong performance continues a trend of exceeding earnings expectations.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+21.38%
Avg 1-day reaction
+1.24%
Analysts expect Merit Medical to continue its strong performance with an EPS of $1.02 and revenue of $409 million. The company has a solid track record of beating earnings estimates, which sets a positive tone for this quarter.
Bull case
If Merit Medical exceeds EPS expectations and shows strong revenue growth, it could indicate robust demand for its products, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet earnings expectations or shows signs of slowing growth, it could raise concerns about its market position and lead to a negative stock reaction.
Key metrics to watch
Earnings Per Share (EPS)
$1.02EPS is a key indicator of the company's profitability and is closely watched by investors.
Revenue
$409MRevenue growth reflects the company's ability to increase sales and capture market share.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $1.02?
A beat on EPS would reinforce the company's strong performance history and could lead to a positive market reaction.
Q2
What are the revenue expectations for this quarter?
Revenue growth is critical for assessing the company's market position and future potential, and any shortfall could raise concerns.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±14.1%
Why consensus could be wrong
The consensus may underestimate the impact of recent product innovations that could drive higher sales than anticipated.
Supporting evidence
The company has consistently beaten EPS estimates, indicating stronger operational performance.
Recent trends in healthcare spending suggest an uptick in demand for medical supplies.
Options pricing indicates a larger potential move than historical averages, suggesting heightened expectations.
Key risk
If revenue comes in significantly above $409 million, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is debating whether Merit Medical can sustain its growth trajectory amid increasing competition and healthcare demands.
Bull confirmed if
Earnings exceeding $1.02 with revenue surpassing $409 million would confirm the bull case.
Bear confirmed if
Earnings below $1.02 or revenue below $409 million would support the bear case.
What the market is pricing for the move.
Implied Move
±17.21%
Historical Avg
±1.9%
The options market is pricing in a significant potential move in either direction, reflecting uncertainty around the earnings report.
Options are pricing ±17.2% while MMSI has averaged ±1.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
42.3%
Smart-money positioning from the most recent 13F filings.
Institutional
107.69%
of float
Insider
2.45%
of float
Holders
548
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
9,464,542 sh · $805.3M
15.85%
7.1%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Merit Medical beats expectations, history suggests the stock could rise by around 0.68%, confirming ongoing strong demand for its products.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.
Miss
If the company misses expectations, history suggests a potential decline of around 0.68%, raising concerns about its growth prospects.
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
3,473,833 sh · $295.6M
5.82%
-1.4%
Vanguard Capital Management LLC
2,590,454 sh · $220.4M
4.34%
-2.5%
State Street Corporation
2,474,512 sh · $210.6M
4.14%
4.8%
Conestoga Capital Advisors, LLC
1,979,790 sh · $168.5M
3.32%
-8.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.